BGI Genomics Monthly Spotlight - April 2024
BGI Genomics
BGI Genomics, based in China, is the world’s leading provider of genetic tests and sequencing services.
Advancing Newborn Genetic Screening Through Prenatal Carrier Screening
A joint study led by Nanjing Women & Children's Healthcare Hospital and Jing-Yu Zhao at BGI Genomics, recently published in the Journal of Global Health, surveyed parents of newborns identified as carriers through genetic screening. This research aimed to gather their perspectives and inform the development of these vital screening programs.
Unlocking Longevity and Innovation: Join Us at ICG-19 in Bangkok
The organizing committee of the ICG-19 is thrilled to announce the 19th International Conference on Genomics Thailand part (ICG-19-THA) will be held at Chulalongkorn University Hospital in Bangkok on May 18th and 19th, 2024.
ICG-19-THA will continue to uphold the spirit of the Human Genome Project (HGP) - "Owned by All, Done by All, Shared by All," advocating for global and human-wide sharing, especially promoting international cooperation among developing countries.
Colorectal Cancer Strikes Younger Than Ever
Over recent decades, the incidence of colorectal cancer (CRC) in individuals under 50 years old, known as early-onset or young-onset CRC, has been rising, according to the American Cancer Society.
Recommended by LinkedIn
Early screening and regular testing can be an effective way to prevent and treat CRC at an early stage. COLOTECT™, a non-invasive test that requires only a stool sample, is available for colorectal cancer screening and can provide medical professionals with evidence to support their diagnosis.
BGI Genomics Unveils First Cutting-Edge Clinical Lab in Uruguay
BGI Genomics has established a new clinical laboratory at Uruguay's Parque de las Ciencias free trade zone. This facility is poised to become a regional hub, advancing preventive medicine across Latin America and utilizing advanced technology to facilitate early disease diagnosis.
It was a true pleasure having BGI Group CEO Dr. Yin Ye, Uruguayan ministers Ana E. Karina Rando Huluk , Omar Paganini , Elisa Facio , Chinese Ambassador Huang Yazhong alongside the fantastic BGI Genomics Uruguay's team attending the event, and it was just as great meeting a lot of new friends.
Navigating the Complexities of Data Security in Biotechnology
The rapid adoption of AI and big data technologies in the biotechnology sector presents unique data privacy and security challenges. To meet these challenges, BGI Genomics actively maintains certifications like ISO/IEC 27001 and BS 10012 while complying with rigorous regulatory standards, including GDPR.
In an insightful interview with AZoMedical, Dr. Fu Wei, Director of Quality Management at BGI Genomics, details the systematic and exhaustive process behind these certifications. This includes comprehensive audits involving document reviews, site visits, and management interviews, emphasizing the company's ongoing commitment to excellence and security.